PharmaVOICE Blog Post

Discover how the language of a disease changes over the patient’s journey

Posted By: Dan Limbach
June 3, 2019

Listening and interpreting the patient’s views throughout their journey of care is an important and elusive goal.

inVibe Labs has developed a lexicon guide for disease states, that helps shed some light on what a patient is saying about their care as they progress through their treatment with their HCP. Download “Speaking RA: Rheumatoid Arthritis Patient Lexicon Guide” for an example of this innovative concept. In this whitepaper, you’ll see how patients in various stages of their therapeutic journey communicate experiences differently and why understanding those language patterns is crucial to addressing their needs.

Download whitepaper: http://bit.ly/invibe-whitepapers

How did inVibe Labs discover this underserved need and develop their system of intuitive (implicit) thinking and reflective (explicit) thinking as it pertains to patients? Find out here: http://bit.ly/invibe-origin

If you are interested in learning more about inVibe, Kathryn Ticknor, Director of Research, is presenting “The Human and the Machine: Empathy-Focused Research in a World of Automation and AI” at IIeX Health’s “The Future of Healthcare and Pharma Insights” conference in Philadelphia on June 4. Click here for more details: https://iiexhealth.insightinnovation.org/agenda/speakers/435171.

About inVibe Labs

inVibe provides healthcare organizations with an entirely new way to listen, enabling them to better understand their customers by capturing authentic stories and translating sound science into actionable insights. inVibe’s structured methodology combined with sociolinguistic analysis and AI-powered speech emotion recognition provides unique customer insights that are used by major pharmaceutical companies, marketing agencies, universities, and healthcare startups. For more information, please visit www.invibe.co.

About the Blog Poster: Dan Limbach

Post a Comment

You must be logged in to post a Comment.

FEEDBACK